v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (13,150) $ (13,446)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 258 204
Stock-based compensation 625 741
Non-cash lease expense 62 114
Gain on derecognition of contract liabilities (335)
Changes in operating assets and liabilities:    
R&D tax credit incentive receivable (55) (241)
Prepaid expenses and other assets (65) 412
Accounts payable 36 933
Accrued compensation expenses (48) 13
Accrued expenses 441 20
Net cash used in operating activities (12,231) (11,250)
Cash flows from investing activities:    
Purchases of property and equipment (102) (76)
Net cash used in investing activities (102) (76)
Cash flows from financing activities:    
Issuance of common stock to related party in connection with 2025 Private Sales Transactions, net 11,589
Issuance of common stock in connection with 2026 Registered Direct Offering, net 2,174
Issuance of common stock to related party in connection with 2026 Private Placement, net 1,997
Payments on insurance premium loan (213) (237)
Net issuance costs in connection with the Sales Agreement (28)
Net cash provided by (used in) financing activities 15,547 (265)
Effect of exchange rate changes on cash and cash equivalents 2 33
Net increase (decrease) in cash, cash equivalents and restricted cash 3,216 (11,558)
Cash, cash equivalents and restricted cash balance at beginning of period 17,570 19,690
Cash, cash equivalents and restricted cash balance at end of period 20,786 8,132
Cash paid during the period for:    
Income taxes 2 2
Non-cash investing and financing activities:    
Purchases of property and equipment in accounts payable and accrued expenses $ (229) $ 12